Population Genomic Screening for Three Common Hereditary Conditions: A Cost-Effectiveness Analysis: Annals of Internal Medicine: Vol 0, No 0 acpjournals.org/doi/10.7326/M2…
Alan Brown MD MHA FACC FNLA
@alanbrownmd
Director, Division of Cardiology
Advocate Lutheran General Hospital
Clinical Lipidologist
Past President, National Lipid Association
Advocate Lutheran General Hospital
Clinical Lipidologist
Past President, National Lipid Association
149 Following 1K Followers 200 Posts
Latest posts 5
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial thelancet.com/journals/lance…
Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases dgfulltext.docguide.com/article/impact… via @docguide
dgfulltext.docguide.com Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a... BACKGROUND Statin treatment increases the risk of new-onset diabetes mellitus (NODM); however, data directly comparing the risk of NODM among individual statins is limited. We compared the risk of... Effect of Alirocumab Added to High-Intensity Statin on Coronary Atherosclerosis in Patients With AMI | comment: Peter Libby MD prac.co/l/y3jyzscd via @practiceupdate